Sens. Klobuchar, Collins push drug-shortage bill

Share this article:
Sen. Susan Collins (R-ME)
Sen. Susan Collins (R-ME)

U.S. senators Amy Klobuchar (D-MN) and Susan Collins (R-ME) are urging their fellow lawmakers to quickly pass a bipartisan bill aimed at addressing the growing drug shortage problem in the U.S.

“The shortages of these vital drugs are causing serious problems around the country,” said Collins in a statement. “Our legislation aims to give the FDA the tools and information they need to prevent drug shortages.”

The Preserving Access to Life-Saving Medications Act, which  Klobuchar introduced  last year, would require drug companies to give  FDA six months notice of any discontinuance, interruption, or other adjustment of a drug's manufacturing process that would likely result in a shortage. Notification would be required for adjustments related to raw materials supply, production capabilities and other reasons deemed appropriate by the HHS secretary.

A stakeholders group has called for exploring incentives such as tax credits for producing critical drug products or upgrading manufacturing plants. They also recommend an expedited approval pathway.
Share this article:
close

Next Article in Features

Email Newsletters

More in Features

FDA and off-label uses: a balancing act

FDA and off-label uses: a balancing act

FDA's current re-examination of its off-label promotion policies in light of the First Amendment is a delicate balancing act between its rock-solid traditional enforcement posture and a diverse new electronic ...

Read the complete August 2014 Digital Edition

Read the complete August 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.